The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: The effect blocked by inhibitors of MAPK/ERK1/2 and PI3-K/Akt pathways

Neurotoxicity Research

Volumn 25, Issue 2, 2014, Pages 208-225

  Jantas, D ^a   Krawczyk, S ^a   Lason, W ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Antidepressant drugs; Apoptosis; MAPK ERK1 2; Necrostatin 1; Neuroprotective drugs; PI3 K Akt; Primary neuronal and glia cell cultures; SH SY5Y cells

Indexed keywords

CASPASE 3; CITALOPRAM; DOXORUBICIN; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REBOXETINE; RETINOIC ACID; STAUROSPORINE; TIANEPTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME REGULATION; GLIAL CELL CULTURE; HUMAN; HUMAN CELL; MOUSE; NECROPTOSIS; NERVE CELL LESION; NEUROBLASTOMA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APOPTOSIS; CELL LINE, TUMOR; DOXORUBICIN; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MICE; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAUROSPORINE; THIAZEPINES;

EID: 84891842786     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9430-3     Document Type: Article

References (72)

1. Abdel-Razaq W, Kendall DA, Bates TE (2011) The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochem Res 36:327-338
2. Argov M, Kashi R, Peer D, Margalit R (2009) Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen. Cancer Lett 274:118-125
3. Bigotte L, Olsson Y (1983) Toxic effects of adriamycin on the central nervous system. Ultrastructural changes in some circumventricular organs of the mouse after intravenous administration of the drug. Acta Neuropathol 61:291-299 (Pubitemid 13015746)
4. Castanon N, Medina C, Mormede C, Dantzer R (2004) Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology 29:778-790 (Pubitemid 38521240)
5. Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D (2011) Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem 18:245-255
6. Chavez-Valdez R, Martin LJ, Flock DL, Northington FJ (2012) Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 219:192-203
7. Chiou SH, Chen SJ, Chang YL, Peng CH, Ku HH, Hsu WM, Ho LL (2006) Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem Biophys Res Commun 343:391-400
8. Christofferson DE, Yuan J (2010) Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22:263-268
9. Chu CC, Wang JJ, Chen KT, Shieh JP, Wang LK, Shui HA, Ho ST (2010) Neurotrophic effects of tianeptine on hippocampal neurons: a proteomic approach. J Proteome Res 9:936-944
10. Chung YC, Kim SR, Park JY, Chung ES, Park KW, Won SY, Bok E, Jin M, Park ES, Yoon SH, Ko HW, Kim YS, Jin BK (2011) Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 60:963-974
11. Cobb JA, Simpson J, Mahajan GJ, Overholser JC, Jurjus GJ, Dieter L, Herbst N, May W, Rajkowska G, Stockmeier CA (2013) Hippocampal volume and total cell numbers in major depressive disorder. J Psychiatr Res 47:299-306
12. Dai MC, Zhong ZH, Sun YH, Sun QF, Wang YT, Yang GY, Bian LG (2013) Curcumin protects against iron induced neurotoxicity in primary cortical neurons by attenuating necroptosis. Neurosci Lett 536:41-46
13. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119
14. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313-321 (Pubitemid 351550892)
15. Della FP, Abelaira HM, Réus GZ, Antunes AR, Dos Santos MA, Zappelinni G, Steckert AV, Vuolo F, Galant LS, Dal-Pizzol F, Kapczinski F, Quevedo J (2012a) Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model. Pharmacol Biochem Behav 103:395-402
16. Della FP, Abelaira HM, Réus GZ, Ribeiro KF, Antunes AR, Scaini G, Jeremias IC, Dos Santos LM, Jeremias GC, Streck EL, Quevedo J (2012b) Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats. Behav Brain Res 233:526-535
17. Della FP, Abelaira HM, Réus GZ, Santos MA, Tomaz DB, Antunes AR, Scaini G, Morais MO, Streck EL, Quevedo J (2013) Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats. Metab Brain Dis 28:93-105
18. Drzyzga ŁR, Marcinowska A, Obuchowicz E (2009) Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies. Brain Res Bull 79:248-257
19. Dunai ZA, Imre G, Barna G, Korcsmaros T, Petak I, Bauer PI, Mihalik R (2012) Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS ONE 7:e41945
20. Fattaccini CM, Bolanos-Jimenez F, Gozlan H, Hamon M (1990) Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 29:1-8 (Pubitemid 20027385)
21. Fuchs E, Czéh B, Kole MH, Michaelis T, Lucassen PJ (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14(Suppl 5):S481-S490 (Pubitemid 39531609)
22. Gabryel B, Adamczyk J, Huzarska M, Pudełko A, Trzeciak HI (2002) Aniracetam attenuates apoptosis of astrocytes subjected to simulated ischemia in vitro. Neurotoxicology 23:385-395
23. Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271:2050-2055 (Pubitemid 38747973)
24. Janda E, Visalli V, Colica C, Aprigliano S, Musolino V, Vadalà N, Muscoli C, Sacco I, Iannone M, Rotiroti D, Spedding M, Mollace V (2011) The protective effect of tianeptine on Gp120-induced apoptosis in astroglial cells: role of GS and NOS, and NF-κB suppression. Br J Pharmacol 164:1590-1599
25. Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K (2009) Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol 16:644-656
26. Jantas D, Lason W (2009) Protective effect of memantine against Doxorubicin toxicity in primary neuronal cell cultures: influence a development stage. Neurotox Res 15:24-37
27. Jantas D, Pytel M, Mozrzymas JW, Leskiewicz M, Regulska M, Antkiewicz-Michaluk L, Lason W (2008) The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 52:864-877
28. Jantas D, Szymanska M, Budziszewska B, Lason W (2009) An involvement of BDNF and PI3-K/Akt in the anti-apoptotic effect of memantine on staurosporine-evoked cell death in primary cortical neurons. Apoptosis 14:900-912
29. Jantas D, Lorenc-Koci E, Kubera M, Lason W (2011) Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons. Neurotoxicology 32:845-856
30. Jantas-Skotniczna D, Kajta M, Lasoń W (2006) Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal cultures. Brain Res 1069:145-153 (Pubitemid 43145907)
31. Ji D, Kamalden TA, del Olmo-Aguado S, Osborne NN (2011) Light- and sodium azide-induced death of RGC-5 cells in culture occurs via different mechanisms. Apoptosis 16:425-437
32. Johann S, Kampmann E, Denecke B, Arnold S, Kipp M, Mey J, Beyer C (2008) Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. J Mol Neurosci 34:177-185
33. Kole MH, Swan L, Fuchs E (2002) The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci 16:807-816 (Pubitemid 35463572)
34. Leskiewicz M, Jantas D, Budziszewska B, Lason W (2008) Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons. J Physiol Pharmacol 59:457-475
35. Leskiewicz M, Jantas D, Regulska M, Kaczanowska J, Basta-Kaim A, Budziszewska B, Kubera M, Lason W (2013) Antidepressants attenuate the dexamethasone-induced decrease in viability and proliferation of human neuroblastoma SH-SY5Y cells: a involvement of extracellular regulated kinase (ERK1/2). Neurochem Int 63:354-362
36. Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A (2005) Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 27:29-42 (Pubitemid 41112377)
37. Lucassen PJ, Fuchs E, Czeh B (2004) Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55:789-796 (Pubitemid 38429869)
38. Malagie I, Deslandes A, Gardier AM (2000) Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 403:55-65
39. Martin JL, Magistretti PJ, Allaman I (2013) Regulation of neurotrophic factors and energy metabolism by antidepressants in astrocytes. Curr Drug Targets 14(11):1308-1321
40. McEwen BS, Olie JP (2005) Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry 10:525-537 (Pubitemid 40897036)
41. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E (2010) The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 15:237-249
42. McKernan DP, Dinan TG, Cryan JF (2009) "Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol 88:246-263
43. Mennini T, Mocaer E, Garattini S (1987) Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch Pharmacol 336:478-482 (Pubitemid 17166835)
44. Moriuchi S, Shimizu K, Miyao Y, Yamada M, Ohkawa M, Hayakawa T (1996) In vitro assessment for neurotoxicity of antitumor agents before local administration into central nervous system. Anticancer Res 16:135-140 (Pubitemid 26128458)
45. Nahon E, Israelson A, Abu-Hamad S, Varda SB (2005) Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. FEBS Lett 579:5105-5110 (Pubitemid 41242861)
46. Northington FJ, Chavez-Valdez R, Martin LJ (2011) Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 69:743-758
47. O'Farrell E, Mackenzie J, Collins B (2013) Clearing the air: a review of our current understanding of "chemo fog". Curr Oncol Rep 15:260-269
48. Pineyro G, Deveault L, de Montigny C, Blier P (1995) Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol 351:119-125
49. Piroli GG, Reznikov LR, Grillo CA, Hagar JM, Fadel JR, Reagan LP (2013) Tianeptine modulates amygdalar glutamate neurochemistry and synaptic proteins in rats subjected to repeated stress. Exp Neurol 241:184-193
50. Plaisant F, Dommergues MA, Spedding M, Cecchelli R, Brillault J, Kato G, Muñoz C, Gressens P (2003) Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology 44:801-819 (Pubitemid 36385144)
51. Qi H, Mailliet F, Spedding M, Rocher C, Zhang X, Delagrange P, McEwen B, Jay TM, Svenningsson P (2009) Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology 56:37-46
52. Rajkowska G (2002) Cell pathology in mood disorders. Semin Clin Neuropsychiatry 7:281-292
53. Rajkowska G, Miguel-Hidalgo JJ (2007) Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6:219-233 (Pubitemid 46916253)
54. Reagan LP, Rosell DR, Wood GE, Spedding M, Munoz C, Rothstein J, McEwen BS (2004) Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 101:2179-2184 (Pubitemid 38229035)
55. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC, Cuny GD, Yuan J, Savitz SI (2010) Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 88:1569-1576
56. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castrén E (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23:349-357 (Pubitemid 36050437)
57. Sairanen M, Lucas G, Ernfors P, Castrén M, Castrén E (2005) Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25:1089-1094 (Pubitemid 40268949)
58. Sairanen M, O'Leary OF, Knuuttila JE, Castrén E (2007) Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 144:368-374 (Pubitemid 44839045)
59. Sawe N, Steinberg G, Zhao H (2008) Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 86:1659-1669 (Pubitemid 351859418)
60. Šimenc J, Lipnik-Štangelj M (2012) Staurosporine induces apoptosis and necroptosis in cultured rat astrocytes. Drug Chem Toxicol 35:399-405
61. Singh S, Misiak M, Beyer C, Arnold S (2010) Brain region specificity of 3-nitropropionic acid-induced vulnerability of neurons involves cytochrome c oxidase. Neurochem Int 57:297-305
62. Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P (2007) Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 26:3509-3517 (Pubitemid 350243523)
63. Szegedi V, Juhász G, Zhang X, Barkóczi B, Qi H, Madeira A, Kapus G, Svenningsson P, Spedding M, Penke B (2011) Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via the p38, p42/44 MAPK and JNK pathways. Neurochem Int 59:1109-1122
64. Tarasenko N, Kessler-Icekson G, Boer P, Inbal A, Schlesinger H, Phillips DR, Cutts SM, Nudelman A, Rephaeli A (2012) The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity. Invest New Drugs 30:130-143
65. Tristão VR, Gonçalves PF, Dalboni MA, Batista MC, Durão Mde S Jr, Monte JC (2012) Nec-1 protects against nonapoptotic cell death in cisplatin-induced kidney injury. Ren Fail 34:373-377
66. Wang YQ, Wang L, Zhang MY, Wang T, Bao HJ, Liu WL, Dai DK, Zhang L, Chang P, Dong WW, Chen XP, Tao LY (2012) Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res 37:1849-1858
67. Xu H, Steven Richardson J, Li XM (2003) Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28:53-62
68. Xu X, Chua CC, Kong J, Kostrzewa RM, Kumaraguru U, Hamdy RC, Chua BH (2007) Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 103:2004-2014 (Pubitemid 350126615)
69. Zhang F, Zhou H, Wilson BC, Shi JS, Hong JS, Gao HM (2012a) Fluoxetine protects neurons against microglial activation-mediated neurotoxicity. Parkinsonism Relat Disord 18(Suppl 1):S213-S217
70. Zhang H, Etherington LA, Hafner AS, Belelli D, Coussen F, Delagrange P, Chaouloff F, Spedding M, Lambert JJ, Choquet D, Groc L (2012b) Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule. Mol Psychiatry 18:471-484
71. Zhang M, Li J, Geng R, Ge W, Zhou Y, Zhang C, Cheng Y, Geng D (2013) The Inhibition of ERK Activation Mediates the Protection of Necrostatin-1 on Glutamate Toxicity in HT-22 Cells. Neurotox Res 24(1):64-70
72. Zhu Y, Culmsee C, Klumpp S, Krieglstein J (2004) Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase 1, 2 signaling pathways. Neuroscience 123:897-906 (Pubitemid 38130100)